Novo Nordisk A/S (NYSE: NVO, CSE: NOVO-B) starts selling the first oral GLP-1 drug for weight loss in the U.S. today. This Wegovy pill gives...
Weight-Loss
In a move that has escalated competition in the growing obesity treatment market, Danish pharmaceutical company Novo Nordisk A/S (NASDAQ: NVO) has made an unsolicited...
